pamidronate has been researched along with technetium tc 99m medronate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AJ; Hosking, DJ; Marshall, DH; Perkins, AC; Stone, MD; Wastie, ML | 1 |
| Boyle, IT; Gallacher, SJ; McKillop, JH; Patel, U | 1 |
| Bouvard, G; Colin, T; Le Gangneux, E; Loyau, G; Macro, M | 1 |
| Davie, MW; Haddaway, MJ | 1 |
| Aburano, T; Inaoka, T; Ishikawa, Y; Makita, Y; Sato, J; Shuke, N; Takahashi, K | 1 |
| Collins, MT; Hill, S; Kovacs, J; Robey, PG; Wientroub, S; Wright, ME; Ziran, N | 1 |
| Higano, CS; King, SH; Ott, SM; Roudier, MP; True, LD; Vessella, RL; Vesselle, H | 1 |
| Kawase, T; Nakayama, H; Okuda, K; Wolff, LF; Yoshie, H | 1 |
8 other study(ies) available for pamidronate and technetium tc 99m medronate
| Article | Year |
|---|---|
Bisphosphonate space measurement in Paget's disease of bone treated with APD.
Topics: Alkaline Phosphatase; Bone and Bones; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Paget Disease, Extramammary; Pamidronate; Regression Analysis; Technetium Tc 99m Medronate | 1992 |
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
Topics: Aged; Aged, 80 and over; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Retrospective Studies; Scotland; Technetium Tc 99m Medronate | 1990 |
Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
Topics: Aged; Bone Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Medronate | 1995 |
Response of 99mTc-MDP scanning and whole-body retention to intravenous pamidronate.
Topics: Aged; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Technetium Tc 99m Medronate; Whole-Body Counting | 1994 |
Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).
Topics: Administration, Oral; Adult; Camurati-Engelmann Syndrome; Diphosphonates; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Pain Measurement; Pain, Intractable; Pamidronate; Prednisolone; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2001 |
Ribbing disease: radiographic and biochemical characterization, lack of response to pamidronate.
Topics: Adult; Anti-Inflammatory Agents; Camurati-Engelmann Syndrome; Diphosphonates; Humans; Magnetic Resonance Imaging; Male; Pamidronate; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2002 |
Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
Topics: Antineoplastic Agents; Autopsy; Bone Neoplasms; Diphosphonates; Humans; Infusions, Intravenous; Male; Pamidronate; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2003 |
In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization.
Topics: Animals; Bone Neoplasms; Calcification, Physiologic; Diphosphonates; Feasibility Studies; Inositol; Mice; Mice, Hairless; Osteosarcoma; Pamidronate; Radiopharmaceuticals; Spectroscopy, Near-Infrared; Technetium Tc 99m Medronate; Transplantation, Heterologous | 2011 |